Etodolac, COX-2 inhibitor NSAID (ab141086)
Key features and details
- COX-2 inhibitor; NSAID
- CAS Number: 41340-25-4
- Purity: > 99%
- Soluble in DMSO to 100 mM and in ethanol to 100 mM
- Form / State: Solid
- Source: Synthetic
Overview
-
Product name
Etodolac, COX-2 inhibitor NSAID -
Description
COX-2 inhibitor; NSAID -
Biological description
COX-2 inhibitor (IC50 values are 12 and 2.2 μM for COX-1 and COX-2, respectively). Non-steroidal anti-inflammatory drug (NSAID).
-
Purity
> 99% -
CAS Number
41340-25-4 -
Chemical structure
Properties
-
Chemical name
1,8-Diethyl-1,3,4,9-tetrahydropyrano[3,4-b]indole-1-acetic acid -
Molecular weight
287.36 -
Molecular formula
C17H21NO3 -
PubChem identifier
3308 -
Storage instructions
Store at +4°C. The product can be stored for up to 12 months. -
Solubility overview
Soluble in DMSO to 100 mM and in ethanol to 100 mM -
Handling
Wherever possible, you should prepare and use solutions on the same day. However, if you need to make up stock solutions in advance, we recommend that you store the solution as aliquots in tightly sealed vials at -20°C. Generally, these will be useable for up to one month. Before use, and prior to opening the vial we recommend that you allow your product to equilibrate to room temperature for at least 1 hour.
Toxic, refer to SDS for further information
Need more advice on solubility, usage and handling? Please visit our frequently asked questions (FAQ) page for more details.
-
SMILES
O=C(O)CC3(CC)OCCc2c3nc1c(cccc12)CC -
Source
Synthetic
-
Research areas
- Metabolism
- Pathways and Processes
- Metabolic signaling pathways
- Nucleotide metabolism
- Molecular processes
- Mitochondrial transcription
- Metabolism
- Pathways and Processes
- Metabolic signaling pathways
- Lipid and lipoprotein metabolism
- Cholesterol Metabolism
Protocols
To our knowledge, customised protocols are not required for this product. Please try the standard protocols listed below and let us know how you get on.
References (0)
ab141086 has not yet been referenced specifically in any publications.